Effect of Secukinumab Versus Adalimumab Biosimilar on Radiographic Progression in Patients With Radiographic Axial Spondyloarthritis: Results From a Head-to-Head Randomized Phase IIIb Study.
Xenofon BaraliakosMikkel ØstergaardDenis PoddubnyyDésirée van der HeijdeAtul A DeodharPedro M MachadoVictoria Navarro-CompánKay-Geert A HermannKishimoto MitsumasaEun Young LeeLianne S GenslerUta KiltzMarco F EigenmannPatricia PertelAimee ReadieHanno B RichardsBrian PorterJuergen BraunPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2024)
Spinal radiographic progression over two years was low with no significant difference between secukinumab and SDZ-ADL arms. The safety of both treatments was consistent with previous reports.